BioAtla (BCAB) Revenue (2020 - 2025)

BioAtla's Revenue history runs 4 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Revenue changed N/A year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $13.0 million, a 18.18% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, down 81.82% from the prior year.
• Revenue fell to $2.0 million in Q4 2025 per BCAB's latest filing, from $11.0 million in the prior quarter.
• Across five years, Revenue topped out at $11.0 million in Q3 2024 and bottomed at $250000.0 in Q2 2021.
• The 3-year median for Revenue is $2.0 million (2025), against an average of $4.4 million.
• Biggest YoY gain for Revenue was 31.58% in 2021; the steepest drop was 31.58% in 2021.
• Year by year, Revenue stood at $250000.0 in 2021, then jumped by 4300.0% to $11.0 million in 2024, then sank by 81.82% to $2.0 million in 2025.
• Per Business Quant, the three latest BCAB Revenue figures stand at $2.0 million (Q4 2025), $11.0 million (Q3 2024), and $250000.0 (Q2 2021).